Body mass index and Barrett's oesophagus in women.

PubWeight™: 1.70‹?› | Rank: Top 3%

🔗 View Article (PMC 2763036)

Published in Gut on March 30, 2009

Authors

B C Jacobson1, A T Chan, E L Giovannucci, C S Fuchs

Author Affiliations

1: Section of Gastroenterology, Department of Medicine, Boston University Medical Center, 88 East Concord Street, Room 7721, Boston, MA 02118, USA. brian.jacobson@bmc.org

Articles citing this

Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol (2014) 2.07

The association between Barrett's esophagus and Helicobacter pylori infection: a meta-analysis. Helicobacter (2012) 1.74

Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2013) 1.56

Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41

Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol (2013) 1.29

Excess body weight and obesity--the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol (2011) 1.18

The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model. Cancer Epidemiol Biomarkers Prev (2011) 0.91

The role of obesity in oesophageal cancer development. Therap Adv Gastroenterol (2014) 0.90

Benign, premalignant, and malignant lesions encountered in bariatric surgery. JSLS (2013) 0.90

Body mass index, smoking, and alcohol and risks of Barrett's esophagus and esophageal adenocarcinoma: a UK prospective cohort study. Dig Dis Sci (2014) 0.83

Obesity and Barrett's oesophagus: more than just reflux. Gut (2009) 0.79

Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus. J Clin Gastroenterol (2016) 0.75

Total body fat and the risk of Barrett's oesophagus - a bioelectrical impedance study. Cancer Epidemiol (2014) 0.75

Impact of Obesity on a Chinese Population with Erosive Esophagitis and Barrett's Esophagus. Gut Liver (2016) 0.75

Reduced Risk of Barrett's Esophagus in Statin Users: Case-Control Study and Meta-Analysis. Dig Dis Sci (2015) 0.75

Articles cited by this

Prevalence of overweight and obesity in the United States, 1999-2004. JAMA (2006) 72.59

Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol (1985) 26.13

Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA (1991) 11.53

Validity of self-reported waist and hip circumferences in men and women. Epidemiology (1990) 10.57

Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer (1998) 10.17

Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol (1994) 9.90

Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51

Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA (2001) 8.40

Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ (2007) 8.00

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol (2008) 7.94

Waist circumference as a measure for indicating need for weight management. BMJ (1995) 7.01

Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med (2006) 5.24

Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology (2000) 4.74

Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med (2005) 4.52

The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med (1985) 4.30

Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30

Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology (2007) 3.94

Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol (1987) 3.77

Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology (1990) 3.77

Obesity: a challenge to esophagogastric junction integrity. Gastroenterology (2006) 3.72

Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56

Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39

Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology (1984) 3.36

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31

Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology (2002) 3.26

Gastroesophageal reflux, barrett esophagus, and esophageal cancer: scientific review. JAMA (2002) 3.11

Clinical practice. Barrett's Esophagus. N Engl J Med (2002) 2.99

Trends in incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol (2000) 2.97

Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol (1999) 2.88

A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol (2007) 2.79

Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA (2003) 2.77

Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol (2005) 2.60

Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology (2003) 2.59

Prevalence of metaplasia at the gastro-oesophageal junction. Lancet (1994) 2.45

Role of acid and duodenogastroesophageal reflux in gastroesophageal reflux disease. Gastroenterology (1996) 2.44

The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther (2005) 2.40

A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol (2008) 2.39

Increasing incidence of Barrett's oesophagus in the general population. Gut (2005) 2.34

Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study. Am J Gastroenterol (2003) 2.34

The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26

Central adiposity and risk of Barrett's esophagus. Gastroenterology (2007) 2.20

Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med (2002) 2.18

Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am (1997) 2.13

New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus. Gut (2006) 2.07

The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. Am J Gastroenterol (1997) 2.03

Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev (2008) 1.89

Association of obesity with hiatal hernia and esophagitis. Am J Gastroenterol (1999) 1.84

Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut (2002) 1.84

Ambulatory oesophageal bile reflux monitoring in Barrett's oesophagus. Br J Surg (1995) 1.83

Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control (1996) 1.82

Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. Am J Gastroenterol (1997) 1.79

Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis. Am J Gastroenterol (2003) 1.73

National Cancer Data Base report on esophageal carcinoma. Cancer (1996) 1.70

Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc (2009) 1.68

Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology (2006) 1.64

A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease. Am J Epidemiol (2005) 1.63

Risk of adenocarcinoma in Barrett's oesophagus: population based study. BMJ (2003) 1.61

Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet (1997) 1.57

Leptin and the risk of Barrett's oesophagus. Gut (2008) 1.54

Waist circumference, waist:hip ratio, and risk of breast cancer in the Nurses' Health Study. Am J Epidemiol (1999) 1.53

Body mass index, height and risk of adenocarcinoma of the oesophagus and gastric cardia: a prospective cohort study. Gut (2007) 1.52

Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation. Endocrinology (2006) 1.52

Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev (2005) 1.49

Overweight, but not high dietary fat intake, increases risk of gastroesophageal reflux disease hospitalization: the NHANES I Epidemiologic Followup Study. First National Health and Nutrition Examination Survey. Ann Epidemiol (1999) 1.43

Distribution of cytokeratin markers in Barrett's specialized columnar epithelium. Gastroenterology (1997) 1.41

Body mass and reflux oesophagitis: an oestrogen-dependent association? Scand J Gastroenterol (2002) 1.31

The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology (1999) 1.28

The association of gastric leptin with oesophageal inflammation and metaplasia. Gut (2007) 1.21

Postmenopausal hormone use and symptoms of gastroesophageal reflux. Arch Intern Med (2008) 1.18

Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease. Arch Surg (2001) 1.04

Barrett's esophagus and obesity: the missing part of the puzzle. Am J Gastroenterol (2008) 0.80

The UK National Barrett's Oesophagus Registry: a study between two centres. Eur J Cancer Prev (1998) 0.78

Articles by these authors

Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol (1992) 17.17

Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc (1993) 9.90

Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell (1992) 9.19

Prospective study of alcohol consumption and risk of coronary disease in men. Lancet (1991) 8.64

Dietary fiber and the risk of colorectal cancer and adenoma in women. N Engl J Med (1999) 6.17

A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12

Cost-effectiveness of screening for colorectal cancer in the general population. JAMA (2000) 5.88

Physical activity, obesity, height, and the risk of pancreatic cancer. JAMA (2001) 4.30

Alcohol consumption and mortality among women. N Engl J Med (1995) 4.22

Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med (1995) 4.06

CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies. Gut (2006) 3.59

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet (1999) 3.54

A prospective study of nutritional factors and hypertension among US men. Circulation (1992) 3.51

Dietary fat and risk of coronary heart disease in men: cohort follow up study in the United States. BMJ (1996) 3.27

Fluid intake and the risk of bladder cancer in men. N Engl J Med (1999) 2.93

Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res (1999) 2.87

Prospective study of plasma fatty acids and risk of prostate cancer. J Natl Cancer Inst (1994) 2.68

Dairy products, calcium, and prostate cancer risk in the Physicians' Health Study. Am J Clin Nutr (2001) 2.64

Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst (2000) 2.46

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer. Br J Cancer (2009) 2.39

A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med (1996) 2.31

Dietary iron intake and risk of coronary disease among men. Circulation (1994) 2.21

Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst (2001) 2.10

How successful is high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys (1998) 2.08

Adherence to the Dietary Guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr (2000) 1.99

A prospective study of carotenoid intake and risk of cataract extraction in US men. Am J Clin Nutr (1999) 1.95

Intake of potassium, magnesium, calcium, and fiber and risk of stroke among US men. Circulation (1998) 1.94

A prospective study of folate intake and the risk of breast cancer. JAMA (1999) 1.83

Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma. Cancer Res (1999) 1.82

Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst (1996) 1.81

Use of acetaminophen and nonsteroidal anti-inflammatory drugs: a prospective study and the risk of symptomatic diverticular disease in men. Arch Fam Med (1998) 1.78

Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma. Clin Cancer Res (1999) 1.77

Thoracoscopic talc insufflation versus talc slurry for symptomatic malignant pleural effusion. Ann Thorac Surg (1996) 1.72

Prospective study of physical activity and the risk of symptomatic diverticular disease in men. Gut (1995) 1.67

A prospective study of diet and the risk of symptomatic diverticular disease in men. Am J Clin Nutr (1994) 1.66

Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J Natl Cancer Inst (2000) 1.64

A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev (2009) 1.60

Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys (1999) 1.59

A prospective study of dietary fiber types and symptomatic diverticular disease in men. J Nutr (1998) 1.54

Fruit and vegetable intake and incidence of bladder cancer in a male prospective cohort. J Natl Cancer Inst (1999) 1.50

Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women. J Natl Cancer Inst (1999) 1.45

The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med (1998) 1.43

Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res (2000) 1.42

Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer (2009) 1.41

Associations of plasma carotenoid concentrations and dietary intake of specific carotenoids in samples of two prospective cohort studies using a new carotenoid database. Cancer Epidemiol Biomarkers Prev (1998) 1.41

Thromboembolic events with paclitaxel. Clin Oncol (R Coll Radiol) (1996) 1.39

Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev (1999) 1.37

A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer. Ann Oncol (2012) 1.34

Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts. Cancer Epidemiol Biomarkers Prev (2001) 1.28

Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. J Pathol (2006) 1.28

Intakes of fruits, vegetables, and related nutrients and the risk of non-Hodgkin's lymphoma among women. Cancer Epidemiol Biomarkers Prev (2000) 1.28

Lovastatin and rhabdomyolysis. Ann Intern Med (1988) 1.23

Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies. Br J Cancer (2010) 1.19

Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev (2001) 1.19

Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression. Cancer Lett (2001) 1.18

A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma. Ann Oncol (2011) 1.16

Prospective study of recreational physical activity and ovarian cancer. J Natl Cancer Inst (2001) 1.16

A prospective study of plasma inflammatory markers and risk of colorectal cancer in men. Br J Cancer (2013) 1.15

A prospective study of alcohol, smoking, caffeine, and the risk of symptomatic diverticular disease in men. Ann Epidemiol (1995) 1.14

Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype. Histopathology (2008) 1.12

Plasma cell-free Epstein-Barr virus DNA quantitation in patients with nasopharyngeal carcinoma. Correlation with clinical staging. Ann N Y Acad Sci (2000) 1.12

Screening endoscopy and risk of colorectal cancer in United States men. Cancer Causes Control (1998) 1.10

Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer. Ann Oncol (2007) 1.10

Kinetics of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma. Cancer Res (2000) 1.10

CTL control of EBV in nasopharyngeal carcinoma (NPC): EBV-specific CTL responses in the blood and tumors of NPC patients and the antigen-processing function of the tumor cells. J Immunol (2000) 1.09

A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men. Epidemiology (1997) 1.07

Central adiposity, regional fat distribution, and the risk of cholecystectomy in women. Gut (2006) 1.07

Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women. Am J Epidemiol (2000) 1.06

Vitamin supplement use and the risk of non-Hodgkin's lymphoma among women and men. Am J Epidemiol (2001) 1.05

Aspirin and lung cancer risk in a cohort study of women: dosage, duration and latency. Br J Cancer (2007) 1.04

IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J Immunol (1994) 1.03

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts. Br J Cancer (2007) 1.01

Novel intertypic recombinants of epstein-barr virus in the chinese population. J Virol (2000) 1.00

Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas. Br J Cancer (2003) 0.99

Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer. Br J Cancer (2010) 0.99

MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr (1999) 0.99

Validation of a food frequency questionnaire measurement of selected nutrients using biological markers in African-American men. Eur J Clin Nutr (2007) 0.99

Gallstones, cholecystectomy, and the risk for developing pancreatic cancer. Br J Cancer (2002) 0.98

Thyroid disease in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.97

Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev (2001) 0.96

Aspirin for the prevention of colorectal cancer. Best Pract Res Clin Gastroenterol (2011) 0.96

Prospective study of diet and the risk of duodenal ulcer in men. Am J Epidemiol (1997) 0.95

A multi-institutional, phase II open-label study of ganitumab (AMG 479) in advanced carcinoid and pancreatic neuroendocrine tumors. Endocr Relat Cancer (2013) 0.94

What causes prostate cancer? A brief summary of the epidemiology. Semin Cancer Biol (1998) 0.93

Dietary carbohydrates and glycaemic load and the incidence of symptomatic gall stone disease in men. Gut (2005) 0.92

Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology (2001) 0.91

Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology (1986) 0.90

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma. Br J Cancer (2006) 0.90

Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States). Cancer Causes Control (1997) 0.90

Prospective study of alcohol consumption patterns in relation to symptomatic gallstone disease in men. Alcohol Clin Exp Res (1999) 0.89